Cargando…
Drug connectivity mapping and functional analysis reveal therapeutic small molecules that differentially modulate myelination
Disruption or loss of oligodendrocytes (OLs) and myelin has devastating effects on CNS function and integrity, which occur in diverse neurological disorders, including Multiple Sclerosis (MS), Alzheimer’s disease and neuropsychiatric disorders. Hence, there is a need to develop new therapies that pr...
Autores principales: | Rivera, A.D., Pieropan, F., Williams, G., Calzolari, F., Butt, A.M., Azim, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editions Scientifiques Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664715/ https://www.ncbi.nlm.nih.gov/pubmed/34813998 http://dx.doi.org/10.1016/j.biopha.2021.112436 |
Ejemplares similares
-
Next generation drug connectivity mapping for acquiring therapeutic agents to differentially regulate myelination
por: Azim, Kasum, et al.
Publicado: (2022) -
Pharmacogenomic identification of small molecules for lineage specific manipulation of subventricular zone germinal activity
por: Azim, Kasum, et al.
Publicado: (2017) -
Functional genomic analyses highlight a shift in Gpr17‐regulated cellular processes in oligodendrocyte progenitor cells and underlying myelin dysregulation in the aged mouse cerebrum
por: Rivera, Andrea D., et al.
Publicado: (2021) -
Targeting the Subventricular Zone to Promote Myelin Repair in the Aging Brain
por: Butt, Arthur Morgan, et al.
Publicado: (2022) -
Connectivity mapping uncovers small molecules that modulate neurodegeneration in Huntington’s disease models
por: Smalley, Joshua L., et al.
Publicado: (2015)